相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatocellular carcinoma (HCC) survival by etiology: A SEER-Medicare database analysis.
Gagandeep Brar et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States
David E. Kaplan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
Victoria Chernyak et al.
RADIOLOGY (2018)
Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?
Yan Zhao et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study
Erqi L. Pollom et al.
RADIOLOGY (2017)
Hepatocellular Carcinoma: A Decade of Hospitalizations and Financial Burden in the United States
Raxitkumar Jinjuvadia et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2017)
Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma
Alessandro Cucchetti et al.
DIGESTIVE AND LIVER DISEASE (2016)
Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach
Vania Tacher et al.
RADIOLOGY (2016)
Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis
Florian Nima Fleckenstein et al.
TRANSLATIONAL ONCOLOGY (2016)
Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - The use of imaging biomarkers as predictors of patient survival
Julius Chapiro et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver
Julius Chapiro et al.
EUROPEAN RADIOLOGY (2015)
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong-Won Park et al.
LIVER INTERNATIONAL (2015)
Brivanib as Adjuvant Therapy to Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: A Randomized Phase III Trial
Masatoshi Kudo et al.
HEPATOLOGY (2014)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization
Rafael Duran et al.
TRANSLATIONAL ONCOLOGY (2014)
Assessment of Liver Tumor Response to Therapy: Role of Quantitative Imaging
Fernanda D. Gonzalez-Guindalini et al.
RADIOGRAPHICS (2013)
Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602
Yozo Sato et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2013)
Quantitative and Volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors Measurements: Feasibility of a Semiautomated Software Method to Assess Tumor Response after Transcatheter Arterial Chemoembolization
MingDe Lin et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
Lack of Response after Initial Chemoembolization for Hepatocellular Carcinoma: Does It Predict Failure of Subsequent Treatment?
Christos Georgiades et al.
RADIOLOGY (2012)
EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolisation
Roopinder Gillmore et al.
JOURNAL OF HEPATOLOGY (2011)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
The burden of illness associated with hepatocellular carcinoma in the United States
Kathleen Lang et al.
JOURNAL OF HEPATOLOGY (2009)
Health-state utilities in liver disease: A systematic review
David J. McLernon et al.
MEDICAL DECISION MAKING (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
